Clinical Trials Directory

Trials / Completed

CompletedNCT03628235

HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

Status
Completed
Phase
Study type
Observational
Enrollment
233 (actual)
Sponsor
CHDI Foundation, Inc. · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Huntington's disease (HD) is a rare, inherited and progressive neurodegenerative disorder for which hallmark symptoms include movement disorders, loss of cognitive faculties and psychiatric disturbances. With the progression of the disease, patients require increasing level of medical care, caregiver support, and long-term care, which lead to substantial burden of illness. Very little data are available on the direct or indirect costs for HD. The direct medical costs of HD in the US have been summarized from retrospective commercial and Medicaid claims data analysis. The indirect and out-of-pocket costs of HD in the US have not been quantified. This study will help to bridge these gaps. This study is a single-assessment, cross-sectional online survey administered to Huntington disease gene expansion carriers (HDGECs) and companions of HDGECs by HD stage to understand the indirect and out-of-pocket costs of Huntington's disease in the US.

Detailed description

The survey collects the following data from each HDGEC and companion: 1. Participant demographics (for HDGECs and companion) 2. Informal care received (for HDGECs only) 3. Out of pocket HD costs (for HDGECs and companion) 4. Current employment status (for HDGECs and companion) 5. Non-work and work care giving time that companion spends taking care of HDGEC (for companion only) 6. Work Productivity and Activity Impairment (WPAI) Questionnaire (for HDGECs and companion)

Conditions

Interventions

TypeNameDescription
BEHAVIORALOnline surveyOnline survey to capture indirect and out of pocket costs of Huntington's Disease in HDGECs and companions

Timeline

Start date
2020-06-21
Primary completion
2022-06-21
Completion
2022-06-21
First posted
2018-08-14
Last updated
2022-09-21

Locations

11 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03628235. Inclusion in this directory is not an endorsement.